| Mr Kent Hon-wah Wong, MD | |
|
3621 Forest Glenn Dr, Modesto, CA 95355-1339 | |
| (209) 521-9661 | |
| (209) 521-9307 |
| Full Name | Mr Kent Hon-wah Wong |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 32 Years |
| Location | 3621 Forest Glenn Dr, Modesto, California |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386628212 | NPI | - | NPPES |
| 1902828841 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | G78664 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Medical Center | Modesto, CA | Hospital |
| Doctors Medical Center | Modesto, CA | Hospital |
| Oak Valley Hospital District | Oakdale, CA | Hospital |
| Emanuel Medical Center | Turlock, CA | Hospital |
| Mercy Medical Center | Merced, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Stanislaus Cardiology Group | 2264468008 | 5 |
News Archive
Kaiser Permanente physician Joel Handler, MD, has been selected to receive a national award from the American Society of Hypertension for his "outstanding dedication to the treatment and care of hypertensive patients." The City of Orange resident is a critical care specialist at Kaiser Permanente's Anaheim Medical Center and has served area residents for over 30 years.
According to a new study, as many as one-third of U.S. military personnel in the war in Iraq received mental health services following their return home, and one in every ten were diagnosed with post-traumatic stress disorder.
Azantis launched today two innovative liposomal products: reduced glutathione and vitamin C. Both oral supplements are formulated in liposomal form to maximize absorption and to minimize side effects. Azantis, a leading phospholipid manufacturer, markets the liposomal products to resellers targeting the health care practitioner channel.
Oxygen Biotherapeutics, Inc. (NASDAQ and SIX Swiss Exchange: OXBT) today announced it has received a $2,075 million two-year grant from the U.S. Army to study the Company's proprietary Oxycyte® PFC emulsion as a therapeutic intervention focused on reducing brain damage in victims of traumatic brain injury (TBI).
Using a novel genetic technology that covers up genetic errors, researchers funded in part by the National Institutes of Health have developed a successful treatment for dogs with the canine version of Duchenne muscular dystrophy, a paralyzing, and ultimately fatal, muscle disease.
› Verified 6 days ago
| Entity Name | Stanislaus Cardiology Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902828841 PECOS PAC ID: 2264468008 Enrollment ID: O20050712001288 |
News Archive
Kaiser Permanente physician Joel Handler, MD, has been selected to receive a national award from the American Society of Hypertension for his "outstanding dedication to the treatment and care of hypertensive patients." The City of Orange resident is a critical care specialist at Kaiser Permanente's Anaheim Medical Center and has served area residents for over 30 years.
According to a new study, as many as one-third of U.S. military personnel in the war in Iraq received mental health services following their return home, and one in every ten were diagnosed with post-traumatic stress disorder.
Azantis launched today two innovative liposomal products: reduced glutathione and vitamin C. Both oral supplements are formulated in liposomal form to maximize absorption and to minimize side effects. Azantis, a leading phospholipid manufacturer, markets the liposomal products to resellers targeting the health care practitioner channel.
Oxygen Biotherapeutics, Inc. (NASDAQ and SIX Swiss Exchange: OXBT) today announced it has received a $2,075 million two-year grant from the U.S. Army to study the Company's proprietary Oxycyte® PFC emulsion as a therapeutic intervention focused on reducing brain damage in victims of traumatic brain injury (TBI).
Using a novel genetic technology that covers up genetic errors, researchers funded in part by the National Institutes of Health have developed a successful treatment for dogs with the canine version of Duchenne muscular dystrophy, a paralyzing, and ultimately fatal, muscle disease.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Kent Hon-wah Wong, MD 3621 Forest Glenn Dr, Modesto, CA 95355-1339 Ph: (209) 521-9661 | Mr Kent Hon-wah Wong, MD 3621 Forest Glenn Dr, Modesto, CA 95355-1339 Ph: (209) 521-9661 |
News Archive
Kaiser Permanente physician Joel Handler, MD, has been selected to receive a national award from the American Society of Hypertension for his "outstanding dedication to the treatment and care of hypertensive patients." The City of Orange resident is a critical care specialist at Kaiser Permanente's Anaheim Medical Center and has served area residents for over 30 years.
According to a new study, as many as one-third of U.S. military personnel in the war in Iraq received mental health services following their return home, and one in every ten were diagnosed with post-traumatic stress disorder.
Azantis launched today two innovative liposomal products: reduced glutathione and vitamin C. Both oral supplements are formulated in liposomal form to maximize absorption and to minimize side effects. Azantis, a leading phospholipid manufacturer, markets the liposomal products to resellers targeting the health care practitioner channel.
Oxygen Biotherapeutics, Inc. (NASDAQ and SIX Swiss Exchange: OXBT) today announced it has received a $2,075 million two-year grant from the U.S. Army to study the Company's proprietary Oxycyte® PFC emulsion as a therapeutic intervention focused on reducing brain damage in victims of traumatic brain injury (TBI).
Using a novel genetic technology that covers up genetic errors, researchers funded in part by the National Institutes of Health have developed a successful treatment for dogs with the canine version of Duchenne muscular dystrophy, a paralyzing, and ultimately fatal, muscle disease.
› Verified 6 days ago
Brian E. Dolnick, DO Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4601 Dale Rd, Modesto, CA 95356 Phone: 209-557-1000 | |
Dr. Joshua Mckee Anderson, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4601 Dale Rd, Modesto, CA 95356 Phone: 209-735-7200 | |
Sulman Razzaq, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1409 E Briggsmore Ave, Modesto, CA 95355 Phone: 209-550-4750 | |
Alvin K Eng, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1540 Florida Ave, # 100, Modesto, CA 95350 Phone: 209-577-5557 Fax: 209-577-8125 | |
Esra Olgun, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 600 Coffee Rd, Modesto, CA 95355 Phone: 209-521-6097 | |
Ronak Chandrakant Shah, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 600 Coffee Rd, Modesto, CA 95355 Phone: 209-521-6097 | |
Dr. Paul Golden, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1330 Nelson Ave, Suite C, Modesto, CA 95350 Phone: 209-576-1547 Fax: 209-576-2736 |